Diabetes mellitus, type 2 Trials in Gdynia, Poland
Conditions / Diabetes mellitus, type 2 / Gdynia, Poland
Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05649137 | A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight | COMPLETED | — |
| NCT01897532 | Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) | COMPLETED | PHASE4 |
| NCT00331851 | Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT00469092 | Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes | COMPLETED | PHASE4 |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT02586155 | Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD | COMPLETED | PHASE3 |
| NCT00968708 | Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome | COMPLETED | PHASE3 |
| NCT01042769 | A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT01991795 | A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |